Your browser doesn't support javascript.
loading
Discovery of TD-0212, an Orally Active Dual Pharmacology AT1 Antagonist and Neprilysin Inhibitor (ARNI).
McKinnell, R Murray; Fatheree, Paul; Choi, Seok-Ki; Gendron, Roland; Jendza, Keith; Olson Blair, Brooke; Budman, Joe; Hill, Craig M; Hegde, Laxminarayan G; Yu, Cecile; McConn, Donavon; Hegde, Sharath S; Marquess, Daniel G; Klein, Uwe.
Afiliação
  • McKinnell RM; Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, United States.
  • Fatheree P; Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, United States.
  • Choi SK; Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, United States.
  • Gendron R; Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, United States.
  • Jendza K; Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, United States.
  • Olson Blair B; Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, United States.
  • Budman J; Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, United States.
  • Hill CM; Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, United States.
  • Hegde LG; Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, United States.
  • Yu C; Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, United States.
  • McConn D; Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, United States.
  • Hegde SS; Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, United States.
  • Marquess DG; Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, United States.
  • Klein U; Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, United States.
ACS Med Chem Lett ; 10(1): 86-91, 2019 Jan 10.
Article em En | MEDLINE | ID: mdl-30655952

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos